Company news
Precision BioSciences, Inc. news in 2019
Precision BioSciences, Inc.'s news releases, calls and decks from 2019, newest first.
Precision BioSciences Welcomes Healthcare Industry Expert, Kevin J. Buehler, to its Board of Directors
November 12, 2019
Precision BioSciences Reports Third Quarter 2019 Financial Results and Highlights Ongoing Operational Progress Including Initial Data from PBCAR0191 Phase 1/2a Clinical Trial
November 11, 2019
Precision BioSciences Announces the Presentation of Initial Clinical Data Supporting the Safety and Clinical Activity of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate, at the American Society of Hematology Annual Meeting
November 5, 2019
Precision BioSciences Appoints Nicholas Riddle, MB, BChir, PhD, as Vice President, Financial Strategy and Investor Relations
September 29, 2019
Precision BioSciences Appoints David Thomson, PhD, as Chief Operating Officer
September 22, 2019
Precision BioSciences Announces FDA Clearance of the IND for PBCAR20A, a CD20 Targeting Genome Edited Allogeneic CAR T Therapy
September 15, 2019
Decks in 2019
- Investor Presentation (November 2019)
Investor deck · 45 slides · Nov 13, 2019
- Investor Presentation (October 2019)
Investor deck · 46 slides · Oct 2, 2019
- Investor Presentation (June 2019)
Investor deck · 32 slides · Jun 7, 2019